Login
$RYTM
$107.48 After hours

Company Executives

Officer Age In this role 2025 pay Source
David P. Meeker Also a director
Chairman of the Board, President and Chief Executive Officer
71 Not stated $17,544,525
Hunter C. Smith
Chief Financial Officer and Treasurer
58 Not stated $6,228,429
Pamela Cramer
Chief Human Resources Officer
52 Since 2021
5 years
Not reported
Joseph Shulman
Chief Technical Officer
51 Since 2022
4 years
Not reported
Alastair Garfield
Chief Scientific Officer
46 Since 2024
2 years
$4,427,024
Manher Joshi
Chief Medical Officer
Title from the Form 4 dated Aug 17, 2026
Not stated Not stated Not reported
Christopher Paul German
Corporate Controller & CAO
Title from the Form 4 dated May 15, 2026
Not stated Not stated Not reported
Jennifer Lee
Executive Vice President, Head of North America
51 Since 2020
6 years
$5,602,816
Yann Mazabraud
Executive Vice President, Head of International
53 Since 2020
6 years
$6,118,455

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 6
stated in the proxy; 1 not stated
Average tenure
7.6 years
from year joined
CEO also chairs the board
Yes
David P. Meeker, M.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
David P. Meeker, M.D.
71 2015
11 years
Not stated None stated Pharvaris GmbH Paid as CEO
Lynn A. Tetrault, J.D.
63 2020
6 years
Independent
Compensation & Management Development Committee · Chair
NeoGenomics, Inc., Alumis, Inc. $669,981
Stuart A. Arbuckle
60 2019
7 years
Independent
Governance & Nominating Committee · Chair
Alnylam Pharmaceuticals, Inc., Praxis Precision Medicines, Inc. $659,981
Jennifer Good
61 2019
7 years
Independent None stated None stated $659,981
Christophe R. Jean
70 2015
11 years
Independent None stated None stated $659,981
David W.J. McGirr
71 2015
11 years
Independent
Audit Committee · Chair
Insmed Incorporated $674,981
Kimberly J. Popovits
67 2026
this year
Independent None stated 10x Genomics, Inc., Kiniksa Pharmaceuticals International, plc Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support